Tiantu Capital appeared to be the VC, which was created in 2002. The main office of represented VC is situated in the Shenzhen. The venture was found in Asia in China.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Tiantu Capital, startups are often financed by Sequoia Capital China, IDG Capital, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, JD.com, ZhenFund. In the next rounds fund is usually obtained by Shunwei Capital, SIG China (SIG Asia Investments), Prometheus Capital.
Besides them, we counted 2 critical employees of this fund in our database.
The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 50 - 100 millions dollars are the general things for fund. The average startup value when the investment from Tiantu Capital is more than 1 billion dollars. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2018. Comparing to the other companies, this Tiantu Capital performs on 20 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 33 percentage points more often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Mobile Apps, E-Commerce. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Guazi (Chehaoduo), Xiaohongshu, Aihuishou The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Xellar Biosystems | $15M | 17 Jul 2024 | Newton, Massachusetts, United States | ||
Recorna Bio | 28 Jun 2024 | Guangzhou, Guangdong, China | |||
Leman Biotech | $7M | 18 Jun 2024 | Lausanne, Vaud, Switzerland | ||
Insight Technology | 22 Mar 2024 | Guangzhou, Guangdong, China | |||
EVENTEC | 30 Oct 2023 | Qingyang District, Sichuan, China | |||
DKJY Beauty Clinic | $4M | 28 Feb 2023 | Tianhe, Hubei, China | ||
Four Leaf Coffee | 29 Jan 2023 | - | |||
Zdeer | 01 Jan 2023 | Jiang'an District, Hubei, China | |||
Highway Store | 01 Dec 2022 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Xellar Biosystems | $15M | 17 Jul 2024 | Newton, Massachusetts, United States | ||
Recorna Bio | 28 Jun 2024 | Guangzhou, Guangdong, China | |||
Leman Biotech | $7M | 18 Jun 2024 | Lausanne, Vaud, Switzerland | ||
Insight Technology | 22 Mar 2024 | Guangzhou, Guangdong, China | |||
EVENTEC | 30 Oct 2023 | Qingyang District, Sichuan, China | |||
DKJY Beauty Clinic | $4M | 28 Feb 2023 | Tianhe, Hubei, China | ||
Four Leaf Coffee | 29 Jan 2023 | - | |||
Zdeer | 01 Jan 2023 | Jiang'an District, Hubei, China | |||
Highway Store | 01 Dec 2022 | - |